What Pharma Executives Secretly Think About the Future (But Won’t Admit Publicly)
The Medical Futurist
MAY 12, 2025
For example, the generative AI model developed in collaboration between NVIDIA and Recursion Pharmaceuticals demonstrated its unique screening prowess. It can screen more than 2.8 With the technology, the traditionally time-consuming and labour-intensive drug design process can be made more efficient.
52 
Let's personalize your content